CRISPR Therapeutics AG (CRSP)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
0/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)42%
Our last 30 days of resolved calls came true 33% of the time.See the track record →
Price
$54.00
1 day
-5.82%
1 week
+2.39%
1 month
+3.65%
1 year
-15.35%
Market cap
$5.3B
Company fundamentals
EPS (TTM)
$-4.76
Debt / Equity
0.34
Current ratio
17.85
Operating margin
-3990.0%
Net margin
-3368.7%
Return on equity
-24.4%
Revenue growth (YoY)
-64.8%
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
Example trade plan · illustrative risk framework
Entry zone
$53.19–$55.08
Stop-loss (exit)
$48.60 −10%
Target (exit)
$64.80 +20%
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
Why it ranks: factor attribution
- QualityRevenue shrinking (-65% y/y)-11
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →